Skip to main content
. 2022 Oct 12;10(6):e00597-22. doi: 10.1128/spectrum.00597-22

TABLE 2.

Variables contributing to the variability observed in the virus neutralization test 1 year after infection

Assay R² for:a
Int100 Slope30 Both Int100, slope30, and clinicalb
VNT 0.744 0.388 0.764 0.770
Abb_S 0.654 0.126 0.701 0.706
Dia_S 0.662 0.005 0.689 0.694
Roc_S 0.670 0.020 0.678 0.714
Sie_S 0.689 0.075 0.713 0.714
Tec_N 0.422 0.003 0.433 0.494
Tec_S 0.652 0.373 0.669 0.680
a

R2 values as a measure for the variability explained by the antibody level at 100 days after infection (int100), the slope of the antibody kinetics within 30 days (slope30), and a combination of both (R2 both).

b

The clinical baseline parameters of age, gender, WHO peak, immunodeficiency, and multimorbidity were additionally considered.